Insights from the largest conference on aging research and drug discovery revealed

The 4-day, 7th Aging Research, and Drug Discovery on-site and online conference organized by the University of Copenhagen, Columbia University, and Deep Longevity scientists attracted over 2,500 delegates

 Wednesday, September 30th, Copenhagen, Denmark -- The laboratory of the biology of aging at the University of Copenhagen, is happy to reveal the online availability of the lectures from the 7th Aging Research, and Drug Discovery (ARDD2020) on-site and online conference organized by the University of Copenhagen, Columbia University, and Deep Longevity scientists. The consented video lectures are available at http://www.AgingPharma.org. 

"It took a small village to be able to complete our Aging Research and Drug Discovery meeting. Huge thanks to everyone at Insilico Medicine and Deep Longevity as well as my co-organizers Alex Zhavoronkov and Daniela Bakula. Also thanks to the CESA staff who helped with the local arrangements. Without all these people the conference would not have reached the level that we did. As a final note, I want to encourage everyone to keep a lookout for next year's meeting. This time hopefully we will be able to meet in person at Columbia University, New York City. ", said Morten Scheibye-Knudsen, MD, Ph.D., the chair of the 7th Aging Research, and Drug Discovery, and head of the biology of the aging laboratory at the center for healthy aging at the University of Copenhagen. 

In 2020 the conference brought together over 2,500 registered delegates from academia, industry, and the government over 4 days with over 70 speakers and panelists. 

"We believe that this is the largest aging research meeting focusing on drug discovery and development to date. I am very happy to see that over the past 7 years since we started the meeting in Basel, it has grown and the longevity industry has evolved, matured, and gained the attention of the pharmaceutical companies and the governments worldwide. Healthy longevity is a fundamental human need and we need to dramatically expand the industry to make people live longer and healthier", said Alex Zhavoronkov, Ph.D., co-founder of ARDD, CEO of Insilico Medicine, and Chief Longevity Officer of Deep Longevity. 

###

About 7th Annual Aging Research and Drug Discovery (ARDD)

The Annual Aging Research and Drug Discovery (ARDD) Conference is an annual scientific conference bringing together academic, government, and industry thought leaders in aging research and longevity biotechnology. Started in 2014 as part of MipTec and later as part of Basel Life Science Week in Basel, Switzerland, the conference grew over the years to become the largest academic and industry meeting spanning 4 days with over 2,500 delegates in 2020 chaired by Morten Scheibye-Knudsen, MD, Ph.D., Daniela Bakula, Ph.D., of the University of Copenhagen and Alex Zhavoronkov, Ph.D. of Deep Longevity and Insilico Medicine. The conference is different from the other events in the field as it focuses on the translational aspect of aging research and has substantial participation from the large pharmaceutical and biotechnology companies and leading clinical centers. In the past, executives from Novartis, Roche, Regeneron, and many other pharmaceutical companies presented their research in aging. The conference materials are available at http://www.AgingPharma.org.